Lalinde-Gutiérrez, Marta

The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

Chaib, S., López-Domínguez, J. A., Lalinde-Gutiérrez, M., Prats, N., Marin, I., Boix, O., García-Garijo, A., Meyer, K., Muñoz, M. I., Aguilera, M., et al. (2024) · Nature Cancer

Telomeres, Telomerase, and SenescenceCancer Immunotherapy and Biomarkers

Cited by 114

Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody–Drug Conjugates in Breast Cancer

Duro-Sánchez, S., Nadal-Serrano, M., Lalinde-Gutiérrez, M., Arenas, E. J., Bernadó Morales, C., Morancho, B., Escorihuela, M., Pérez-Ramos, S., Escrivá-de-Romaní, S., Gandullo-Sánchez, L., et al. (2022) · Cancer Research

HER2/EGFR in Cancer ResearchTelomeres, Telomerase, and Senescence

Cited by 45

Data from Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody–Drug Conjugates in Breast Cancer

Duro-Sánchez, S., Nadal-Serrano, M., Lalinde-Gutiérrez, M., Arenas, E. J., Bernadó Morales, C., Morancho, B., Escorihuela, M., Pérez-Ramos, S., Escrivá-de-Romaní, S., Gandullo-Sánchez, L., et al. (2023)

HER2/EGFR in Cancer ResearchTelomeres, Telomerase, and Senescence

Cited by 0